Elevated serum pre-arrest cathepsin D concentrations are associated with higher mortality in in-hospital cardiac arrest

IF 8.8 1区 医学 Q1 CRITICAL CARE MEDICINE
Taline Lazzarin, Paula Schmidt Azevedo, Leonardo Antonio Mamede Zornoff, Sergio Alberto Rupp de Paiva, Filipe Welson Leal Pereira, Raquel Simões Ballarin, Marcos Ferreira Minicucci
{"title":"Elevated serum pre-arrest cathepsin D concentrations are associated with higher mortality in in-hospital cardiac arrest","authors":"Taline Lazzarin, Paula Schmidt Azevedo, Leonardo Antonio Mamede Zornoff, Sergio Alberto Rupp de Paiva, Filipe Welson Leal Pereira, Raquel Simões Ballarin, Marcos Ferreira Minicucci","doi":"10.1186/s13054-025-05382-y","DOIUrl":null,"url":null,"abstract":"<p>Cathepsin D (CatD) is a lysosomal enzyme implicated in ischemia–reperfusion injury, influencing apoptosis and inflammatory cytokine production [1]. It has been associated with cardiovascular diseases, atherosclerosis, heart failure, and acute conditions such as acute kidney injury (AKI) and pancreatitis [2]. However, its role in cardiac arrest (CA) remains unexplored. Therefore, this study aimed to evaluate the association between pre-arrest CatD levels, return of spontaneous circulation (ROSC), and mortality in in-hospital cardiac arrest (IHCA) patients.</p><p>An ambispective cohort study was conducted between August 2021 and April 2023 involving IHCA patients. Ethics approval was obtained (46,717,721.0.0000.5411), and the sample size was calculated using the CatD mean in patients with and without coronary artery disease [3], with a significance level of 5% and a power of 80%, resulting in a required sample size of 170 patients.</p><p>Eligible patients were those aged &gt; 18 years who suffered IHCA, underwent cardiopulmonary resuscitation (CPR), and had blood samples available within 48 h before CA. Only index CA events were considered. Data were extracted from electronic medical records, including demographic, laboratory, and clinical variables. Serum pre-arrest CatD levels were measured using ELISA (Elabscience®) from blood samples available in the laboratory that were collected in the last 48 h before CA. The primary outcomes were sustained ROSC (≥ 20 min) and in-hospital mortality.</p><p>Statistical analyses were performed using SigmaPlot v12.0 and Stata v15.1. Continuous variables were analyzed using Student’s t-test or Mann–Whitney test, while categorical variables were assessed using the χ<sup>2</sup> or Fisher's exact test. A receiver operating characteristic (ROC) curve was used to evaluate the predictive performance of pre-arrest CatD for in-hospital mortality. Due to the high mortality rate, penalized likelihood estimation with Firth logistic regression was applied, adjusting for clinically relevant and statistically significant variables. A significance level of 5% was adopted.</p><p>We included 199 patients (mean age 66.4 ± 15.5 years; 56.2% male). ROSC occurred in 43.7% of cases, while in-hospital mortality reached 95.0%, with only ten patients surviving. The cerebral performance category (CPC) scale classified 40% of survivors as CPC 1, 30% as CPC 2, and 30% as CPC 3, indicating that 70% had a good neurological outcome. Initial non-shockable rhythm, prolonged CPR, epinephrine use, elevated urea, and high pre-arrest CatD levels were associated with mortality (Table 1). Median pre-arrest CatD levels were significantly higher in non-survivors (39.9 pg/L) than in survivors (7.2 pg/L). ROC analysis demonstrated a strong association between pre-arrest CatD and mortality (AUC 0.822; CI 0.7142–0.9302; p &lt; 0.001—supplementary Fig. 1) at a cutoff of 33.2 pg/L (sensitivity 56.6%, specificity 90%). Firth's penalized logistic regression confirmed that elevated pre-arrest CatD levels were an independent predictor of in-hospital mortality (supplementary Table 1), although no association with ROSC was observed.</p><figure><figcaption><b data-test=\"table-caption\">Table 1 Baseline characteristics and laboratory data of 199 patients with in-hospital cardiac arrest according to in-hospital mortality</b></figcaption><span>Full size table</span><svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-chevron-right-small\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></figure><p>This study is the first to demonstrate an association between elevated pre-arrest CatD levels and in-hospital mortality in IHCA patients. Unlike previous research that assessed biomarkers after CA, our analysis focused on pre-arrest samples collected within 48 h before CA, providing insight into pre-arrest deterioration rather than ischemia–reperfusion effects.</p><p>IHCA is a critical condition with poor outcomes [4]. Identifying early biomarkers could facilitate early intervention, prioritization of intensive care, and resource allocation. Given its established role in cardiovascular and inflammatory diseases, pre-arrest CatD demonstrated strong prognostic potential in our study, with an AUC exceeding 0.8.</p><p>CatD has been implicated in various pathophysiological processes. In heart failure, elevated CatD levels have been associated with disease severity, higher mortality, and greater hospitalization rates. In atherosclerosis, CatD contributes to plaque instability. In AKI, CatD promotes tubular cell damage, while its inhibition has been shown to improve renal function and reduce apoptosis. In pancreatitis, CatD exacerbates inflammation and apoptosis. Furthermore, CatD plays a role in cancer aggressiveness, with antibody-mediated inhibition demonstrating therapeutic potential [2, 5]. Considering these findings, CatD may serve as a marker of poor health status preceding cardiac arrest.</p><p>Given the above considerations, we hypothesize that elevated pre-arrest CatD levels contribute to poor outcomes via apoptosis, protease activation, and inflammatory pathways, exacerbating post-CA injury. Notably, targeting CatD could represent a potential therapeutic strategy to mitigate adverse outcomes in critically ill patients, including those with IHCA.</p><p>This study has limitations, including its single-center design and high mortality rate. Additionally, information regarding the withdrawal of care was unavailable. Nevertheless, our findings provide novel insights into CatD as a potential prognostic biomarker in IHCA. This study demonstrates that increased serum pre-arrest CatD levels, measured within 48 h before IHCA, are independently associated with high in-hospital mortality. Future research should explore CatD’s mechanistic role and potential therapeutic target to improve IHCA outcomes.</p><p>Due to institutional policy, the datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author upon reasonable request. No datasets were generated or analysed during the current study.</p><dl><dt style=\"min-width:50px;\"><dfn>CA:</dfn></dt><dd>\n<p>Cardiac arrest</p>\n</dd><dt style=\"min-width:50px;\"><dfn>IHCA:</dfn></dt><dd>\n<p>In-hospital cardiac arrest</p>\n</dd><dt style=\"min-width:50px;\"><dfn>CatD:</dfn></dt><dd>\n<p>Cathepsin D</p>\n</dd><dt style=\"min-width:50px;\"><dfn>AKI:</dfn></dt><dd>\n<p>Acute kidney injury</p>\n</dd><dt style=\"min-width:50px;\"><dfn>ROSC:</dfn></dt><dd>\n<p>Return of spontaneous circulation</p>\n</dd><dt style=\"min-width:50px;\"><dfn>CPR:</dfn></dt><dd>\n<p>Cardiopulmonary resuscitation</p>\n</dd><dt style=\"min-width:50px;\"><dfn>ROC:</dfn></dt><dd>\n<p>Receiver operating characteristic</p>\n</dd></dl><ol data-track-component=\"outbound reference\" data-track-context=\"references section\"><li data-counter=\"1.\"><p>Huertas J, Lee HT. Multi-faceted roles of cathepsins in ischemia-reperfusion injury (Review). Mol Med Rep. 2022;26(6):368.</p><p>Article CAS PubMed PubMed Central Google Scholar </p></li><li data-counter=\"2.\"><p>Mijanovic O, Petushkova AI, Brankovic A, Turk B, Solovieva AB, Nikitkina AI, et al. Cathepsin D—managing the delicate balance. Pharmaceutics. 2021;13(6):837.</p><p>Article CAS PubMed PubMed Central Google Scholar </p></li><li data-counter=\"3.\"><p>Mohammadpour AH, Salehinejad Z, Elyasi S, Mouhebati M, Mirhafez SR, Samadi S, et al. Evaluation of serum cathepsin D concentrations in coronary artery disease. Indian Heart J. 2018;70(4):471–5.</p><p>Article PubMed PubMed Central Google Scholar </p></li><li data-counter=\"4.\"><p>Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA. 2019;321(12):1200.</p><p>Article PubMed PubMed Central Google Scholar </p></li><li data-counter=\"5.\"><p>Desroys Du Roure P, Lajoie L, Mallavialle A, Alcaraz LB, Mansouri H, Fenou L, et al. A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. J Immunother Cancer. 2024;12(1):e007135.</p><p>Article PubMed PubMed Central Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><p>None</p><p>This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP—2022/15993-4).</p><h3>Authors and Affiliations</h3><ol><li><p>Internal Medicine Department, Botucatu Medical School, São Paulo State University (UNESP), Rubião Junior S/N, Botucatu, SP, 18618-970, Brazil</p><p>Taline Lazzarin, Paula Schmidt Azevedo, Leonardo Antonio Mamede Zornoff, Sergio Alberto Rupp de Paiva, Filipe Welson Leal Pereira, Raquel Simões Ballarin &amp; Marcos Ferreira Minicucci</p></li></ol><span>Authors</span><ol><li><span>Taline Lazzarin</span>View author publications<p><span>You can also search for this author in</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Paula Schmidt Azevedo</span>View author publications<p><span>You can also search for this author in</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Leonardo Antonio Mamede Zornoff</span>View author publications<p><span>You can also search for this author in</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Sergio Alberto Rupp de Paiva</span>View author publications<p><span>You can also search for this author in</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Filipe Welson Leal Pereira</span>View author publications<p><span>You can also search for this author in</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Raquel Simões Ballarin</span>View author publications<p><span>You can also search for this author in</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Marcos Ferreira Minicucci</span>View author publications<p><span>You can also search for this author in</span><span>PubMed<span> </span>Google Scholar</span></p></li></ol><h3>Contributions</h3><p>TL: conceptualization, methodology, formal analysis, writing—original draft; PSA, LAMZ, SARP, FWLP, RSB: methodology, formal analysis, writing—review &amp; editing; MFM: conceptualization, methodology, writing—review &amp; editing, visualization, supervision. All authors finalized the version submitted and agreed to be accountable for all aspects of the work.</p><h3>Corresponding author</h3><p>Correspondence to Taline Lazzarin.</p><h3>Ethics approval and consent to participate</h3>\n<p>This study was approved by the Ethics Committee of our Institution (46717721.0.0000.5411).</p>\n<h3>Consent for publication</h3>\n<p>Not applicable.</p>\n<h3>Competing interests</h3>\n<p>The authors declare no competing interests.</p><h3>Publisher's Note</h3><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p><h3>13054_2025_5382_MOESM1_ESM.docx</h3><p>Additional file 1 Supplementary Fig. 1. ROC curve for the association between pre-arrest Cathepsin D level and in-hospital mortality (area under the ROC curve 0.822; CI 0.7142–0.9302; p &lt; 0.001). Description of data: ROC curve analysis.</p><h3>13054_2025_5382_MOESM2_ESM.docx</h3><p>Additional file 2 Supplementary Table 1. Firth's penalized logistic regression for prediction of the in-hospital mortality in 199 patients with in-hospital cardiac arrest. Description of data: Firth's penalized logistic regression analysis.</p><p><b>Open Access</b> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.</p>\n<p>Reprints and permissions</p><img alt=\"Check for updates. Verify currency and authenticity via CrossMark\" height=\"81\" loading=\"lazy\" src=\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\" width=\"57\"/><h3>Cite this article</h3><p>Lazzarin, T., Azevedo, P.S., Zornoff, L.A.M. <i>et al.</i> Elevated serum pre-arrest cathepsin D concentrations are associated with higher mortality in in-hospital cardiac arrest. <i>Crit Care</i> <b>29</b>, 134 (2025). https://doi.org/10.1186/s13054-025-05382-y</p><p>Download citation<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><ul data-test=\"publication-history\"><li><p>Received<span>: </span><span><time datetime=\"2025-02-13\">13 February 2025</time></span></p></li><li><p>Accepted<span>: </span><span><time datetime=\"2025-03-20\">20 March 2025</time></span></p></li><li><p>Published<span>: </span><span><time datetime=\"2025-03-24\">24 March 2025</time></span></p></li><li><p>DOI</abbr><span>: </span><span>https://doi.org/10.1186/s13054-025-05382-y</span></p></li></ul><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button data-track=\"click\" data-track-action=\"get shareable link\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Get shareable link</button><p>Sorry, a shareable link is not currently available for this article.</p><p data-track=\"click\" data-track-action=\"select share url\" data-track-label=\"button\"></p><button data-track=\"click\" data-track-action=\"copy share url\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Copy to clipboard</button><p> Provided by the Springer Nature SharedIt content-sharing initiative </p>","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"9 1","pages":""},"PeriodicalIF":8.8000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13054-025-05382-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Cathepsin D (CatD) is a lysosomal enzyme implicated in ischemia–reperfusion injury, influencing apoptosis and inflammatory cytokine production [1]. It has been associated with cardiovascular diseases, atherosclerosis, heart failure, and acute conditions such as acute kidney injury (AKI) and pancreatitis [2]. However, its role in cardiac arrest (CA) remains unexplored. Therefore, this study aimed to evaluate the association between pre-arrest CatD levels, return of spontaneous circulation (ROSC), and mortality in in-hospital cardiac arrest (IHCA) patients.

An ambispective cohort study was conducted between August 2021 and April 2023 involving IHCA patients. Ethics approval was obtained (46,717,721.0.0000.5411), and the sample size was calculated using the CatD mean in patients with and without coronary artery disease [3], with a significance level of 5% and a power of 80%, resulting in a required sample size of 170 patients.

Eligible patients were those aged > 18 years who suffered IHCA, underwent cardiopulmonary resuscitation (CPR), and had blood samples available within 48 h before CA. Only index CA events were considered. Data were extracted from electronic medical records, including demographic, laboratory, and clinical variables. Serum pre-arrest CatD levels were measured using ELISA (Elabscience®) from blood samples available in the laboratory that were collected in the last 48 h before CA. The primary outcomes were sustained ROSC (≥ 20 min) and in-hospital mortality.

Statistical analyses were performed using SigmaPlot v12.0 and Stata v15.1. Continuous variables were analyzed using Student’s t-test or Mann–Whitney test, while categorical variables were assessed using the χ2 or Fisher's exact test. A receiver operating characteristic (ROC) curve was used to evaluate the predictive performance of pre-arrest CatD for in-hospital mortality. Due to the high mortality rate, penalized likelihood estimation with Firth logistic regression was applied, adjusting for clinically relevant and statistically significant variables. A significance level of 5% was adopted.

We included 199 patients (mean age 66.4 ± 15.5 years; 56.2% male). ROSC occurred in 43.7% of cases, while in-hospital mortality reached 95.0%, with only ten patients surviving. The cerebral performance category (CPC) scale classified 40% of survivors as CPC 1, 30% as CPC 2, and 30% as CPC 3, indicating that 70% had a good neurological outcome. Initial non-shockable rhythm, prolonged CPR, epinephrine use, elevated urea, and high pre-arrest CatD levels were associated with mortality (Table 1). Median pre-arrest CatD levels were significantly higher in non-survivors (39.9 pg/L) than in survivors (7.2 pg/L). ROC analysis demonstrated a strong association between pre-arrest CatD and mortality (AUC 0.822; CI 0.7142–0.9302; p < 0.001—supplementary Fig. 1) at a cutoff of 33.2 pg/L (sensitivity 56.6%, specificity 90%). Firth's penalized logistic regression confirmed that elevated pre-arrest CatD levels were an independent predictor of in-hospital mortality (supplementary Table 1), although no association with ROSC was observed.

Table 1 Baseline characteristics and laboratory data of 199 patients with in-hospital cardiac arrest according to in-hospital mortality
Full size table

This study is the first to demonstrate an association between elevated pre-arrest CatD levels and in-hospital mortality in IHCA patients. Unlike previous research that assessed biomarkers after CA, our analysis focused on pre-arrest samples collected within 48 h before CA, providing insight into pre-arrest deterioration rather than ischemia–reperfusion effects.

IHCA is a critical condition with poor outcomes [4]. Identifying early biomarkers could facilitate early intervention, prioritization of intensive care, and resource allocation. Given its established role in cardiovascular and inflammatory diseases, pre-arrest CatD demonstrated strong prognostic potential in our study, with an AUC exceeding 0.8.

CatD has been implicated in various pathophysiological processes. In heart failure, elevated CatD levels have been associated with disease severity, higher mortality, and greater hospitalization rates. In atherosclerosis, CatD contributes to plaque instability. In AKI, CatD promotes tubular cell damage, while its inhibition has been shown to improve renal function and reduce apoptosis. In pancreatitis, CatD exacerbates inflammation and apoptosis. Furthermore, CatD plays a role in cancer aggressiveness, with antibody-mediated inhibition demonstrating therapeutic potential [2, 5]. Considering these findings, CatD may serve as a marker of poor health status preceding cardiac arrest.

Given the above considerations, we hypothesize that elevated pre-arrest CatD levels contribute to poor outcomes via apoptosis, protease activation, and inflammatory pathways, exacerbating post-CA injury. Notably, targeting CatD could represent a potential therapeutic strategy to mitigate adverse outcomes in critically ill patients, including those with IHCA.

This study has limitations, including its single-center design and high mortality rate. Additionally, information regarding the withdrawal of care was unavailable. Nevertheless, our findings provide novel insights into CatD as a potential prognostic biomarker in IHCA. This study demonstrates that increased serum pre-arrest CatD levels, measured within 48 h before IHCA, are independently associated with high in-hospital mortality. Future research should explore CatD’s mechanistic role and potential therapeutic target to improve IHCA outcomes.

Due to institutional policy, the datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author upon reasonable request. No datasets were generated or analysed during the current study.

CA:

Cardiac arrest

IHCA:

In-hospital cardiac arrest

CatD:

Cathepsin D

AKI:

Acute kidney injury

ROSC:

Return of spontaneous circulation

CPR:

Cardiopulmonary resuscitation

ROC:

Receiver operating characteristic

  1. Huertas J, Lee HT. Multi-faceted roles of cathepsins in ischemia-reperfusion injury (Review). Mol Med Rep. 2022;26(6):368.

    Article CAS PubMed PubMed Central Google Scholar

  2. Mijanovic O, Petushkova AI, Brankovic A, Turk B, Solovieva AB, Nikitkina AI, et al. Cathepsin D—managing the delicate balance. Pharmaceutics. 2021;13(6):837.

    Article CAS PubMed PubMed Central Google Scholar

  3. Mohammadpour AH, Salehinejad Z, Elyasi S, Mouhebati M, Mirhafez SR, Samadi S, et al. Evaluation of serum cathepsin D concentrations in coronary artery disease. Indian Heart J. 2018;70(4):471–5.

    Article PubMed PubMed Central Google Scholar

  4. Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA. 2019;321(12):1200.

    Article PubMed PubMed Central Google Scholar

  5. Desroys Du Roure P, Lajoie L, Mallavialle A, Alcaraz LB, Mansouri H, Fenou L, et al. A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. J Immunother Cancer. 2024;12(1):e007135.

    Article PubMed PubMed Central Google Scholar

Download references

None

This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP—2022/15993-4).

Authors and Affiliations

  1. Internal Medicine Department, Botucatu Medical School, São Paulo State University (UNESP), Rubião Junior S/N, Botucatu, SP, 18618-970, Brazil

    Taline Lazzarin, Paula Schmidt Azevedo, Leonardo Antonio Mamede Zornoff, Sergio Alberto Rupp de Paiva, Filipe Welson Leal Pereira, Raquel Simões Ballarin & Marcos Ferreira Minicucci

Authors
  1. Taline LazzarinView author publications

    You can also search for this author inPubMed Google Scholar

  2. Paula Schmidt AzevedoView author publications

    You can also search for this author inPubMed Google Scholar

  3. Leonardo Antonio Mamede ZornoffView author publications

    You can also search for this author inPubMed Google Scholar

  4. Sergio Alberto Rupp de PaivaView author publications

    You can also search for this author inPubMed Google Scholar

  5. Filipe Welson Leal PereiraView author publications

    You can also search for this author inPubMed Google Scholar

  6. Raquel Simões BallarinView author publications

    You can also search for this author inPubMed Google Scholar

  7. Marcos Ferreira MinicucciView author publications

    You can also search for this author inPubMed Google Scholar

Contributions

TL: conceptualization, methodology, formal analysis, writing—original draft; PSA, LAMZ, SARP, FWLP, RSB: methodology, formal analysis, writing—review & editing; MFM: conceptualization, methodology, writing—review & editing, visualization, supervision. All authors finalized the version submitted and agreed to be accountable for all aspects of the work.

Corresponding author

Correspondence to Taline Lazzarin.

Ethics approval and consent to participate

This study was approved by the Ethics Committee of our Institution (46717721.0.0000.5411).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

13054_2025_5382_MOESM1_ESM.docx

Additional file 1 Supplementary Fig. 1. ROC curve for the association between pre-arrest Cathepsin D level and in-hospital mortality (area under the ROC curve 0.822; CI 0.7142–0.9302; p < 0.001). Description of data: ROC curve analysis.

13054_2025_5382_MOESM2_ESM.docx

Additional file 2 Supplementary Table 1. Firth's penalized logistic regression for prediction of the in-hospital mortality in 199 patients with in-hospital cardiac arrest. Description of data: Firth's penalized logistic regression analysis.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Abstract Image

Cite this article

Lazzarin, T., Azevedo, P.S., Zornoff, L.A.M. et al. Elevated serum pre-arrest cathepsin D concentrations are associated with higher mortality in in-hospital cardiac arrest. Crit Care 29, 134 (2025). https://doi.org/10.1186/s13054-025-05382-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13054-025-05382-y

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

开放存取 本文采用知识共享署名-非商业性-禁止衍生 4.0 国际许可协议进行许可,该协议允许以任何媒介或格式进行任何非商业性使用、共享、分发和复制,只要您适当注明原作者和来源,提供知识共享许可协议的链接,并说明您是否修改了许可材料。根据本许可协议,您无权分享源自本文或本文部分内容的改编材料。本文中的图片或其他第三方材料均包含在文章的知识共享许可协议中,除非在材料的信用栏中另有说明。如果材料未包含在文章的知识共享许可协议中,且您打算使用的材料不符合法律规定或超出了许可使用范围,则您需要直接获得版权所有者的许可。如需查看该许可的副本,请访问 http://creativecommons.org/licenses/by-nc-nd/4.0/.Reprints and permissionsCite this articleLazzarin, T., Azevedo, P.S., Zornoff, L.A.M. et al. Elevated serum pre-arrest cathepsin D concentrations are associated with higher mortality in hospital cardiac arrest.Crit Care 29, 134 (2025)。https://doi.org/10.1186/s13054-025-05382-yDownload citationReceived:13 February 2025Accepted: 2025 March 2025Published: 24 March 2025DOI: https://doi.org/10.1186/s13054-025-05382-yShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Critical Care
Critical Care 医学-危重病医学
CiteScore
20.60
自引率
3.30%
发文量
348
审稿时长
1.5 months
期刊介绍: Critical Care is an esteemed international medical journal that undergoes a rigorous peer-review process to maintain its high quality standards. Its primary objective is to enhance the healthcare services offered to critically ill patients. To achieve this, the journal focuses on gathering, exchanging, disseminating, and endorsing evidence-based information that is highly relevant to intensivists. By doing so, Critical Care seeks to provide a thorough and inclusive examination of the intensive care field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信